This dataset contains the clinical and epidemiological data of all paratyphoid cases collected in our surveillance.

The following information is provided: Randomized_ID: ID of the isolates included in this study. Sites_F: Hospital/health care facility from which the sample was collected (BSHI: Bangladesh Shishu Hospital and Insitute, SSFH: Shishu Shashtya Foundation Hospital, PDC1,2 and 3: Popular Diagnostic centers). IPDOPD: Department where the sample was collected from (IPD: In-patient department; OPD: out-patient department). BloodReceiveDate: Date of blood collection. Year: Year of blood collection. Sex: Sex of the child (Male, Female, Data not found). AgeInMonths: Age of the child in months. AmpicillinZCat: Categorical reading from the disc diffusion test for Ampicillin based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). ChloramphenicolZCat: Categorical reading from the disc diffusion test for Chloramphenicol based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). CotrimoxazoleZCat: Categorical reading from the disc diffusion test for Cotrimoxazole based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). CiprofloxacinZCat: Categorical reading from the disc diffusion test for Ciprofloxacin based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). CeftriaxoneZCat: Categorical reading from the disc diffusion test for Ceftriaxone based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). AzithromycinZCat: Categorical reading from the disc diffusion test for Azithromycin based on CLSI guidelines (Susceptible, Intermediate, Resistant, Data not found). Isolate_available: If the Isolate was Biobanked (Yes, No). CIPMIC: MIC determined using dilution testing for Ciprofloxacin. CIPMIC_Cat: Categorical reading of the MIC test for Ciprofloxacin based on CLSI guidelines (Susceptible, Intermediate and Resistant). CROMIC: MIC determined using dilution testing for Ceftriaxone. CROMIC_Cat: Categorical reading of the MIC test for Ceftriaxone based on CLSI guidelines (Susceptible, Intermediate and Resistant).
(XLSX)